A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.66 NZD -0.37% Market Closed
Market Cap: 279m NZD

Wall Street
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 3.13 NZD and a high forecast of 4.52 NZD.

Lowest
Price Target
3.13 NZD
18% Upside
Average
Price Target
3.77 NZD
42% Upside
Highest
Price Target
4.52 NZD
70% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets
ORX
Orexo AB
109% Upside
IPN
Ipsen SA
23% Upside
605507
Guobang Pharma Ltd
42% Upside
SUVENPHAR
Suven Pharmaceuticals Ltd
41% Upside
ORMP
Oramed Pharmaceuticals Inc
56% Upside
NATCOPHARM
Natco Pharma Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
AFT Pharmaceuticals Ltd

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 2 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AFT Pharmaceuticals Ltd

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's operating income is 26%. The projected CAGR for the next 3 years is 38%.

26%
Past Growth
38%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
AFT Pharmaceuticals Ltd

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's net income is 43%. The projected CAGR for the next 2 years is 39%.

43%
Past Growth
39%
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFT's stock price target?
Price Target
3.77 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 3.13 NZD and a high forecast of 4.52 NZD.

What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
19%

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 2 years is 19%.

What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
38%

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's operating income is 26%. The projected CAGR for the next 3 years is 38%.

What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
39%

For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's net income is 43%. The projected CAGR for the next 2 years is 39%.

Back to Top